Hema Metrics gains FDA nod for urea check:
This article was originally published in Clinica
Hema Metrics, of Lowell, Massachusetts, has gained FDA 510(k) approval to market in the US its urea reduction ratio (URR) feature as a complementary product to its Crit-Line haemodialysis control technology. The URR product is based on real-time changes in urea nitrogen concentration in spent dialysate during haemodialysis. The company notes that the URR technology further extends the capability of its Crit-Line dialysis monitor and will support its growth into the haemodialysis market, notes the company.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.